Evaluation of predictive models in daily practice for the identification of patients with Lynch syndrome
Open Access
- 25 April 2011
- journal article
- early detection-and-diagnosis
- Published by Wiley in International Journal of Cancer
- Vol. 130 (6) , 1367-1377
Abstract
The optimal strategy for identifying patients with Lynch syndrome among patients with newly diagnosed colorectal cancer (CRC) is still debated. Several predictive models (e.g., MMRpredict, PREMM1,2 and MMRpro) combining personal and familial data have recently been developed to quantify the risk that a given patient with CRC carries a Lynch syndrome‐causing mutation. Their clinical applicability to patients with CRC from the general population requires evaluation. We studied a consecutive series of 214 patients with newly diagnosed CRC characterized for tumor microsatellite instability (MSI), somatic BRAF mutation, MLH1 promoter methylation and mismatch repair (MMR) gene germline mutation status. The performances of the models for identifying MMR mutation carriers (8/214, 3.7%) were evaluated and compared to the revised Bethesda guidelines and a molecular strategy based on MSI testing in all patients followed by the exclusion of MSI‐positive sporadic cases from mutational testing by screening for BRAF mutation and MLH1 promoter methylation. The sensitivities of the three models, at the lowest thresholds proposed, were identical (75%), with similar numbers of probands eligible for further MSI testing (almost half the patients). In our dataset, the prediction models gave no better discrimination than the revised Bethesda guidelines. Both approaches failed to identify two of the eight mutation carriers (the same two patients, aged 67 and 81 years, both with no family history). Thus, like the revised Bethesda guidelines, predictive models did not identify all patients with Lynch syndrome in our series of consecutive CRC. Our results support systematic screening for MMR deficiency in all new CRC cases.Keywords
This publication has 42 references indexed in Scilit:
- Performance of clinical guidelines compared with molecular tumour screening methods in identifying possible Lynch syndrome among colorectal cancer patients: a Norwegian population-based studyBritish Journal of Cancer, 2010
- Identifying Lynch syndromeInternational Journal of Cancer, 2009
- Feasibility of Screening for Lynch Syndrome Among Patients With Colorectal CancerJournal of Clinical Oncology, 2008
- Comparison of predictive models, clinical criteria and molecular tumour screening for the identification of patients with Lynch syndrome in a population-based cohort of colorectal cancer patientsJournal of Medical Genetics, 2008
- Pathology Features in Bethesda Guidelines Predict Colorectal Cancer Microsatellite Instability: A Population-Based StudyGastroenterology, 2007
- Prediction of Germline Mutations and Cancer Risk in the Lynch SyndromeJAMA, 2006
- Use of Microsatellite Instability and Immunohistochemistry Testing for the Identification of Individuals at Risk for Lynch SyndromeFamilial Cancer, 2005
- Screening for the Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer)New England Journal of Medicine, 2005
- Testing guidelines for hereditary non-polyposis colorectal cancerNature Reviews Cancer, 2004
- The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)Diseases of the Colon & Rectum, 1991